Skip to main content
Caplight Logo









Dilafor

Dilafor

Private
SolnaHealthcare & Life Scienceshttps://www.dilafor.com/

Last Round

VC Round

Apr 23, 2019

Est. Valuation

$23.01M

Company Overview

Dilafor is a drug discovery company that develops pharmaceutical products aimed at minimizing the risk for maternal and fetal complications associated with labor.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

women's healthclinical-stage pharmalabor and deliverytafoxiparinlabor inductionprolonged laborobstetricsmaternal healthpharmaceutical licensingdrug developmentheparan sulfate mimeticbiotechnologyoutpatient drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dilafor Comparables

Compare Dilafor with similar companies based on industry and business-model similarity.

Dilafor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pfizer
73%
Gedeon Richter Plc.
66%
Bayer AG
62%

Dilafor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 23, 2019
VC RoundSep 27, 2016
Corporate FundingOct 8, 2014

Dilafor Investors

Notable investors and investment history

Dilafor investors
InvestorRounds
Rosetta CapitalVC Round
The Foundation for Baltic and East European StudiesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors increased 120% MoM.

  • Jan 2, 2026

    Monthly visitors increased 1169% MoM, reaching 1K.

Dilafor Filings

Explore SEC and related filing metadata, where available.

Dilafor filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dilafor's valuation, stock price, and market status.

Is Dilafor a public or private company?

Dilafor is a private company.

What is the current stock price of Dilafor?

Dilafor is a private company with no public stock price. No recent secondary market data is available.

How much is Dilafor worth (valuation)?

Valuation information for Dilafor is not publicly available.

Can I buy Dilafor stock?

Dilafor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dilafor's last funding round?

Funding round information for Dilafor is not publicly available.

Who are the main investors in Dilafor?

Investor information for Dilafor is not publicly disclosed.

Will Dilafor IPO soon?

No public IPO plans have been announced for Dilafor.

How can I track Dilafor secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dilafor's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSolna
Employee Range4
Year Founded2003
Last FundingApr 23, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?